Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Militia Hill Ventures is a venture capital firm based in the greater Philadelphia area, dedicated to creating and investing in life sciences companies. The firm focuses on accelerating life science innovations and has a portfolio of five notable companies. They employ an active 'build' approach to develop high-quality, fast-growing companies in the biotech and healthcare sectors.
This firm invests in life sciences companies, particularly in gene therapy, regenerative medicine, and cancer immunotherapy. They participate in pre-seed, seed, Series A, Series B, and growth equity stages, utilizing their extensive network and domain expertise to support portfolio companies.
Notable portfolio companies include Spirovant Sciences, developing a gene therapy for cystic fibrosis; Immunome, focused on novel cancer therapies using the human immune system; Tmunity Therapeutics, innovating in T cell immunotherapy; Eliksa Therapeutics, addressing unmet medical needs in ocular and cardiovascular indications; and RiboNova, developing treatments for inherited mitochondrial disease.
Email info@militiahillventures.com with your deck to pitch them.
Yes, Militia Hill Ventures often leads investment rounds in their portfolio companies, particularly in the early stages of development.
The firm is open to follow-on investments, especially for companies that demonstrate significant growth potential and align with their focus areas.
Specific fund size details are not disclosed, but the firm actively invests across multiple stages in the life sciences sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.